Ownership

James A. Mcnulty

Insider Reports History

Entity: Individual
Location: C/O Cv Sciences, Inc., 2688 S. Rainbow Blvd., Suite B, Las Vegas, NV
Signature: /s/ James A. McNulty
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James A. Mcnulty:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Inhibitor Therapeutics, Inc.	Chief Financial Officer	Common Stock	1.95M			Dec 2, 2024	Direct
RENOVARO INC.	Director	Option to purchase shares of common stock	121K			Nov 4, 2024	Direct
Inhibitor Therapeutics, Inc.	Chief Financial Officer	Stock Option	100K			Mar 16, 2024	Direct

Showing 1 to 3 of 3 entries

Insider Reports Filed by James A. Mcnulty

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
INTI	Inhibitor Therapeutics, Inc.	Dec 31, 2024	1	$0	5	Feb 19, 2025	Chief Financial Officer
RENB	RENOVARO INC.	Nov 4, 2024	1	$0	4	Nov 6, 2024	Director
RENB	RENOVARO INC.	Oct 14, 2024	0	$0	3	Oct 23, 2024	Director
INTI	Inhibitor Therapeutics, Inc.	Mar 16, 2024	1	$0	4	May 16, 2024	CHIEF FINANCIAL OFFICER, 10%+ Owner
INTI	Inhibitor Therapeutics, Inc.	May 5, 2023	3	$0	4	May 17, 2023	Chief Financial Officer, Treasurer, Secretary of the Company, 10%+ Owner
INTI	Inhibitor Therapeutics, Inc.	Dec 13, 2022	0	$0	3	Dec 22, 2022	Chief Financial Officer, Treasurer, Secretary of the Company, 10%+ Owner